August 12, 2013 | Blog | By Daniel Herling
California has a reputation for many things: 8th largest economy in the World; land of fruits and nuts and a state not being overly business friendly.
August 8, 2013 | Blog | By Howie Miller
On August 5, 2013 the FDA issued its final rule on the voluntary labeling of food gluten-free. This is good news for both consumers and manufacturers.
August 6, 2013 | Blog | By Matthew Howsare
When you board a ride at an amusement park, the question of who regulates the ride vs. the toy you just won is probably the last thing on your mind.
August 2, 2013 | Blog | By Daniel Herling
Contract clauses impacting risk assumption and risk transfer which are integral to the capturing of recall costs are often relegated to the “boiler plate” section of many Supply Agreements or are preprinted on the reverse side of POs that are often not sent by PDF or fax.
August 1, 2013 | Blog | By Matthew Cohen
Starting in 2012, the U.S. Consumer Product Safety Commission (CPSC) teamed up with football helmet manufacturers, the National Football League (NFL), and others to eliminate the use of outdated football helmets and teach safer game play among youth football players.
July 29, 2013 | Blog | By Michelle Gillette
Manufacturers are removing “natural” statements from their labels, both as part of lawsuit settlements and as an alternate marketing strategy. PepsiCo has agreed to remove the phrase from its Naked juices after a lawsuit was filed against it in California, stating that it will wait for more detailed regulatory guidance on the term.
July 13, 2013 | Blog | By Michelle Gillette
In what may be an indication of things to come, the Food Court (US District Court Northern District of California) has decided to ask FDA for guidance on what it wants on food labels.
July 10, 2013 | Blog | By Matthew Howsare
The National Institute of Standards and Technology (NIST) has issued guidelines to help federal agencies manage and secure mobile devices used by their employees for government business.
July 5, 2013 | Blog | By Michelle Gillette
Some are concerned that the potential health consequence of the use of genetically modified organisms in food is unknown because of the lack of long-term testing proving that it is safe.
July 3, 2013 | Blog | By Matthew Howsare
On June 27th, the U.S. Senate confirmed Marietta Robinson and Ann Marie Buerkle as new CPSC Commissioners. Robinson was first nominated in 2012 and participated in a hearing before the Senate Committee on Commerce, Science, and Transportation on May 10, 2012. Buerkle was nominated in late May of this year and confirmed by the Senate one month later without having a Senate hearing.
June 28, 2013 | Blog | By Michelle Gillette
When should a court decide a case that has issues involving an area that Congress has already weighed in on?
June 26, 2013 | Blog | By Charles Samuels
A unanimous U.S. Consumer Product Safety Commission (“CPSC”) announced that Ross Stores Inc. (“Ross”), a national discount retailer, agreed to pay a $3.9 million civil penalty to settle allegations that it failed to report its continued sale of banned children’s upper outerwear containing drawstrings.
June 20, 2013 | Blog | By Michelle Gillette
Are you for or against GMOs? Do you think the government should get involved? Whether for or against legislation requiring labeling showing any Genetically Modified Organism contained in your food, the fact that the two sides are diametrically opposed on interpretation of critical aspects will ensure litigation.
June 12, 2013 | Blog | By Michelle Gillette
It’s 2 o’clock in the afternoon, you need a snack – maybe a granola bar, but which one? Does the package that boasts it is “100% Natural” win out over the one that is only “All Natural”?
June 3, 2013 | Blog | By Matthew Cohen
The U.S. Consumer Product Safety Commission (“CPSC”) recently proposed to substantially alter its 2008 regulation governing the form and contents of certificates of compliance for consumer products.
Explore Other Viewpoints:
- Arbitration, Mediation & Alternate Dispute Resolution
- Bankruptcy & Restructuring
- Class Action
- Complex Commercial Litigation
- Consumer Product Safety
- Debt Financing
- EB-5 Financing
- Education & Nonprofits
- Employment, Labor & Benefits
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPR's & Other Post Grant Proceedings
- Insolvency & Creditor Rights Litigation
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Products Liability & Complex Tort
- Project Development & Finance
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Sports & Entertainment
- Strategic IP Monetization & Licensing
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations